• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清中游离及与载脂蛋白B相关的脂蛋白A特异性蛋白

Free and Apo B-associated Lpa-specific protein in human serum.

作者信息

Gries A, Nimpf J, Nimpf M, Wurm H, Kostner G M

出版信息

Clin Chim Acta. 1987 Apr 15;164(1):93-100. doi: 10.1016/0009-8981(87)90110-0.

DOI:10.1016/0009-8981(87)90110-0
PMID:2953508
Abstract

The distribution of Lpa-specific protein (Apo A) among various fractions of human serum was investigated. The following results were obtained. In very low density lipoproteins (VLDL) of fasting human serum Apo A cannot be detected. Most of Apo A is complexed to LDL forming lipoprotein a (Lpa) present in the density fraction of 1.006-1.125 g/ml. Only approximately 5% of Apo A are found in the d greater than 1.125 bottom fraction after ultracentrifugation. Phosphotungstate-Mg (PTA), heparin-Mn (Hep) and dextran sulfate-Mg (DS) precipitate approximately 95% of serum Lpa together with the Apo B containing lipoproteins. Also monospecific antibodies against Apo B do not precipitate all Lpa and leave approximately 3% of Apo A in the supernatant. With polyethylene glycol (PEG) on the other hand, virtually all Lpa is removed since this reagent also precipitates Lpa and Apo A. Apo A of the bottom fraction after ultracentrifugation and of the supernatant after selective precipitation is not stainable with Sudan black and probably represents a protein which is not associated with lipids.

摘要

研究了人血清不同组分中Lpa特异性蛋白(载脂蛋白A)的分布情况。得到了以下结果。在空腹人血清的极低密度脂蛋白(VLDL)中无法检测到载脂蛋白A。大部分载脂蛋白A与低密度脂蛋白结合形成脂蛋白a(Lpa),存在于密度为1.006 - 1.125 g/ml的组分中。超速离心后,仅约5%的载脂蛋白A存在于密度大于1.125的底部组分中。磷钨酸镁(PTA)、肝素锰(Hep)和硫酸葡聚糖镁(DS)会沉淀约95%的血清Lpa以及含载脂蛋白B的脂蛋白。同样,抗载脂蛋白B的单特异性抗体也不能沉淀所有Lpa,上清液中会残留约3%的载脂蛋白A。另一方面,聚乙二醇(PEG)几乎能去除所有Lpa,因为该试剂也会沉淀Lpa和载脂蛋白A。超速离心后底部组分以及选择性沉淀后上清液中的载脂蛋白A不能被苏丹黑染色,可能代表一种不与脂质相关的蛋白质。

相似文献

1
Free and Apo B-associated Lpa-specific protein in human serum.人血清中游离及与载脂蛋白B相关的脂蛋白A特异性蛋白
Clin Chim Acta. 1987 Apr 15;164(1):93-100. doi: 10.1016/0009-8981(87)90110-0.
2
Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.人受试者中Lp(a)而非紧密结合的载脂蛋白(a)与富含甘油三酯的脂蛋白的关联。
Biochim Biophys Acta. 1997 Jun 23;1346(3):261-74. doi: 10.1016/s0005-2760(97)00049-0.
3
Precipitation of apo E-containing lipoproteins by precipitation reagents for apolipoprotein B.用于载脂蛋白B的沉淀试剂对含载脂蛋白E的脂蛋白的沉淀作用。
Clin Chem. 1984 Nov;30(11):1784-8.
4
Heterogeneity of lipoprotein Lp(a) and apolipoprotein(a).脂蛋白Lp(a)和载脂蛋白(a)的异质性。
Clin Chem. 1988 Jun;34(6):1036-40.
5
Development of a lipoprotein profile using capillary electrophoresis and mass spectrometry.使用毛细管电泳和质谱法开发脂蛋白谱。
Electrophoresis. 1997 Sep;18(10):1796-806. doi: 10.1002/elps.1150181014.
6
Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.低密度脂蛋白、高密度脂蛋白及其亚组分中的胆固醇浓度,以及载脂蛋白AI和AII与冠状动脉狭窄和左心室功能的关联。
J Lab Clin Med. 1987 Jan;109(1):19-26.
7
Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.透析类型对血清脂质、载脂蛋白和脂蛋白的影响。
Ren Fail. 2006;28(7):567-71. doi: 10.1080/08860220600839761.
8
Cholesterol determination in serum after fractionation of lipoproteins by immunoprecipitation.通过免疫沉淀法分离脂蛋白后血清中胆固醇的测定。
Clin Chem. 1985 Feb;31(2):252-6.
9
Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction.
Biochim Biophys Acta. 1995 Mar 2;1255(1):31-8. doi: 10.1016/0005-2760(94)00213-i.
10
Lipoprotein heterogeneity and its effect on apolipoprotein assays.脂蛋白异质性及其对载脂蛋白检测的影响。
Scand J Clin Lab Invest Suppl. 1990;198:51-7.

引用本文的文献

1
Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin.使用新型异构体不敏感免疫测定法测量脂蛋白(a)颗粒说明了莫瓦拉普林的疗效。
J Lipid Res. 2025 Jan;66(1):100723. doi: 10.1016/j.jlr.2024.100723. Epub 2024 Dec 6.
2
Current Management and Future Perspectives in the Treatment of Lp(a) with a Focus on the Prevention of Cardiovascular Diseases.脂蛋白(a)治疗的当前管理及未来展望:聚焦心血管疾病的预防
Pharmaceuticals (Basel). 2023 Jun 23;16(7):919. doi: 10.3390/ph16070919.
3
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.
载脂蛋白(a)与心血管疾病风险:聚焦糖尿病患者载脂蛋白(a)悖论。
Int J Mol Sci. 2022 Mar 25;23(7):3584. doi: 10.3390/ijms23073584.
4
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.全基因组特征分析与遗传性心血管风险升高相关的高穿透性脂蛋白(a)血症。
Circ Genom Precis Med. 2022 Apr;15(2):e003489. doi: 10.1161/CIRCGEN.121.003489. Epub 2022 Feb 8.
5
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.脂蛋白(a):一种与遗传相关的、因果性的、普遍存在的动脉粥样硬化性心血管疾病风险因素:美国心脏协会的科学声明。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.
6
Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.脂蛋白(a):反叛者——对脂蛋白(a)分子的结构、功能、代谢、致病性及相关药物的新见解
J Lipids. 2020 Feb 1;2020:3491764. doi: 10.1155/2020/3491764. eCollection 2020.
7
Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients.探究2型糖尿病患者中脂蛋白(a)的动脉粥样硬化风险。
Cureus. 2018 Jul 23;10(7):e3030. doi: 10.7759/cureus.3030.
8
The metabolism of lipoprotein (a): an ever-evolving story.脂蛋白(a)的代谢:一个不断发展的故事。
J Lipid Res. 2017 Sep;58(9):1756-1764. doi: 10.1194/jlr.R077693. Epub 2017 Jul 18.
9
Lipoprotein (a): a historical appraisal.脂蛋白(a):历史评价
J Lipid Res. 2017 Jan;58(1):1-14. doi: 10.1194/jlr.R071571. Epub 2016 Nov 7.
10
Linkage between the loci for the Lp(a) lipoprotein (LP) and plasminogen (PLG).脂蛋白(a)[Lp(a)]与纤溶酶原(PLG)基因座之间的连锁关系。
Hum Genet. 1988 May;79(1):80-2. doi: 10.1007/BF00291716.